Target Name: MIR3177
NCBI ID: G100423012
Review Report on MIR3177 Target / Biomarker Content of Review Report on MIR3177 Target / Biomarker
MIR3177
Other Name(s): hsa-miR-3177-5p | mir-3177 | MicroRNA 3177 | hsa-miR-3177-3p | hsa-mir-3177 | microRNA 3177

MIR3177: A Rising Star as a Drug Target and Biomarker

In recent years, microRNAs (miRNAs) have gained significant attention as potential therapeutic targets and biomarkers in various diseases. These small non-coding RNA molecules have been found to play a crucial role in post-transcriptional regulation of gene expression, making them attractive candidates for drug discovery and diagnostic purposes. Among the emerging miRNAs, MIR3177 has emerged as a rising star, showing promise as both a drug target and a biomarker in different pathologies. This article will delve into the exciting potential of MIR3177 in the field of medicine.

What is MIR3177?

MIR3177 is a highly conserved and evolutionarily ancient miRNA that has been identified in many species, including humans. It is located on chromosome 1q32.1 and belongs to the miR-154 family. Despite being relatively new to the miRNA landscape, MIR3177 has already stirred considerable interest due to its involvement in critical biological processes and potential clinical applications.

MIR3177 as a Drug Target

One of the most compelling aspects of MIR3177 lies in its potential as a drug target, particularly in the field of cancer research. Studies have shown that aberrant expression of MIR3177 is associated with multiple cancer types, including breast, lung, colorectal, and hepatocellular carcinoma. In some cases, downregulation of MIR3177 has been observed, while in others, its upregulation is responsible for disease progression.

By modulating the expression of MIR3177, researchers believe they can potentially halt cancer growth and metastasis. Strategies such as antisense oligonucleotides (ASOs) and small interfering RNA (siRNA) have shown promise in preclinical studies by successfully targeting MIR3177 and inhibiting cancer cell proliferation. This holds great potential for the development of targeted therapies that could complement or even replace current treatment options.

Moreover, recent research has demonstrated the involvement of MIR3177 in drug resistance, a major hurdle in cancer treatment. It has been suggested that manipulating MIR3177 levels could sensitize cancer cells to chemotherapy drugs, rendering them more susceptible to treatment.

MIR3177 as a Biomarker

Apart from its potential as a drug target, MIR3177 also shines as a potential biomarker for various diseases. Due to its tissue-specific expression patterns and stability, MIR3177 has been identified as a potential diagnostic and prognostic marker in numerous conditions.

For instance, in Alzheimer's disease, studies have shown that MIR3177 levels in cerebrospinal fluid and serum are significantly altered compared to healthy controls. These alterations correlate with disease severity, making MIR3177 a possible tool for detecting and monitoring Alzheimer's progression.

Similarly, in cardiovascular diseases, dysregulated MIR3177 expression has been observed. In patients with heart failure, increased levels of circulating MIR3177 have been associated with adverse outcomes, suggesting its potential as a prognostic marker for monitoring disease progression and treatment response.

In addition to neurodegenerative and cardiovascular diseases, MIR3177 has also been explored as a biomarker in diabetes, autoimmune diseases, and viral infections. Its dynamic expression in different pathologies makes it an attractive candidate for the development of non-invasive diagnostic tests, facilitating early detection and personalized medicine approaches.

The Future of MIR3177

The rising star status of MIR3177 in the field of medicine suggests a promising future ahead. As our understanding of the intricate roles of miRNAs expands, researchers are likely to uncover more therapeutic opportunities and diagnostic potentials for MIR3177.

Moreover, advancements in drug delivery systems, such as nanoparticle-based carriers, offer a viable route for targeted delivery of MIR3177-modulating agents to specific tissues and cells. This could enhance the efficacy and minimize off-target effects, paving the way for more efficient and safer therapies.

In conclusion, MIR3177 has emerged as a promising miRNA with vast potential as both a drug target and a biomarker. Its involvement in critical cellular processes, association with various diseases, and potential for targeted therapy and non-invasive diagnostics make it an exciting focus of ongoing research. As we unravel the mystique surrounding MIR3177, we may witness groundbreaking advancements in the prevention, diagnosis, and treatment of a wide range of diseases.

Protein Name: MicroRNA 3177

The "MIR3177 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3177 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183 | MIR3184 | MIR3185 | MIR3186 | MIR3187 | MIR3188 | MIR3189 | MIR3190 | MIR3191 | MIR3192 | MIR3193 | MIR3194 | MIR3195 | MIR3196 | MIR3197 | MIR3198-1 | MIR3199-1 | MIR3199-2 | MIR31HG | MIR32 | MIR3200 | MIR3201 | MIR3202-1 | MIR3202-2 | MIR320A | MIR320B1 | MIR320B2 | MIR320C1 | MIR320C2 | MIR320D1 | MIR320D2 | MIR320E | MIR323A | MIR323B | MIR324 | MIR325 | MIR325HG | MIR326 | MIR328 | MIR329-1 | MIR329-2 | MIR330 | MIR331 | MIR335 | MIR337 | MIR338 | MIR339 | MIR33A | MIR33B | MIR340 | MIR342 | MIR345 | MIR346 | MIR34A | MIR34AHG | MIR34B | MIR34C | MIR3529 | MIR3591 | MIR3605 | MIR3606 | MIR3609 | MIR361 | MIR3610 | MIR3611 | MIR3612 | MIR3613 | MIR3614 | MIR3615 | MIR3616 | MIR3617 | MIR3618 | MIR3619 | MIR362 | MIR3620 | MIR3621 | MIR3622A | MIR3622B | MIR363 | MIR3646 | MIR3648-1 | MIR3649 | MIR3650 | MIR3651 | MIR3652 | MIR3654 | MIR3655 | MIR3658 | MIR3659 | MIR365A